| sumatriptan succinate / Generic mfg. |
NCT01430442: Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine |
|
|
| Completed | 2b | 1026 | US | Rimegepant, Placebo, Sumatriptan, Imitrex® | Pfizer | Migraine, Acute Treatment of Migraine | 05/12 | 05/12 | | |
|
|
2006-002677-41: Neuropeptides in the human intra - and extracerebral circulation - before and after affecting the trigeminovascular system with sumatriptan in healthy volunteers. |
|
|
| Ongoing | 2 | 16 | Europe | Sumatriptan, Injection* | Danishy Headache Center, KAS Glostrup, Dep. N01 | healthy volunteers | | | | |
NCT00530517: A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack |
|
|
| Completed | 2 | 54 | US | Intraject Sumatriptan | Zogenix, Inc. | Migraine Headache | 10/07 | 10/07 | | |
NCT00804973: Study in Participants With Acute Migraines Headaches |
|
|
| Terminated | 2 | 120 | US | LY2590443, Placebo injection, Sumatriptan, Placebo capsule | Eli Lilly and Company | Migraine Headache | 05/09 | 05/09 | | |
NCT00920686: Study of NXN 188 for the Treatment of Migraine With Aura |
|
|
| Completed | 2 | 239 | US | NXN-188, NXN-188 dihydrochloride, placebo, placebo capsules, sumatriptan succinate | NeurAxon Inc. | Migraine With Aura | 03/10 | 03/10 | | |
2010-019058-42: Safety of sumatriptan in combination with lithium for treatment of cluster headache, Pilot Study,Phase II |
|
|
| Terminated | 2 | 50 | Europe | Capsule, hard, Solution for injection, CARBOLITHIUM, IMIGRAN*SC 2SIR 6MG | AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI | Cluster Headache | | | | |
| Completed | 2 | 75 | Europe, US | BGG492, Sumatriptan, Placebo | Novartis | Migraine | 08/10 | 08/10 | | |
|
NCT01791400: Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache |
|
|
| Completed | 2 | 124 | RoW | metoclopramide, injection,20mg, one time, plasil, Sumatriptan, injection, 6 mg, one time | Isfahan University of Medical Sciences | Migraine Disorders | 11/10 | 11/10 | | |
2007-002435-93: Evaluation d\'une solution hydro-alcoolique de sumatriptan administrée par voie sublinguale dans le traitement d\'une crise d\'algie vasculaire de la face, à la dose de 2mg, 4mg ou 6mg déterminée par une première partie d\'étude en \"dose-ranging\". |
|
|
| Ongoing | 2 | 30 | Europe | SL07, SL07, | UNITHER PHARMACEUTICALS | Cluster headaches | | | | |
NCT02176655: Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches |
|
|
| Completed | 2 | 31 | US | VVD-101, sumatriptan succinate 12.5 mg & acetylsalicylic acid 325 mg, Placebo | Cady, Roger, M.D., Vivid Pharma Inc. | Delayed Alcohol Induced Headache | 01/16 | 01/16 | | |
NCT01854385: Sumatriptan as Treatment for Post-traumatic Headache |
|
|
| Completed | 2 | 40 | US | Sumatriptan 100 mg, Imitrex, Imigran | University of Washington | Post-traumatic Headache | 02/18 | 02/18 | | |
